Gweneth Lazenby to Cost-Benefit Analysis
This is a "connection" page, showing publications Gweneth Lazenby has written about Cost-Benefit Analysis.
Connection Strength
0.222
-
Cost-effectiveness analysis of annual Trichomonas vaginalis screening and treatment in HIV-positive women to prevent HIV transmission. Sex Transm Dis. 2014 Jun; 41(6):353-8.
Score: 0.096
-
A cost-effectiveness analysis of anal cancer screening in HIV-positive women. J Low Genit Tract Dis. 2012 Jul; 16(3):275-80.
Score: 0.084
-
The cost of Medicaid savings: the potential detrimental public health impact of neonatal circumcision defunding. Infect Dis Obstet Gynecol. 2012; 2012:540295.
Score: 0.022
-
Cost-effectiveness of maternal treatment to prevent perinatal hepatitis B virus transmission. Obstet Gynecol. 2011 Sep; 118(3):655-662.
Score: 0.020